Aurora Cannabis Appoints Kerry Miller to Boost Growth in Australia and New Zealand Markets

Aurora Cannabis Strengthens Global Presence with New Appointment in Australia and New Zealand

Aurora Cannabis Inc., a prominent player in the global medical cannabis industry, announces the appointment of Kerry Miller as the Managing Director for Australia and New Zealand, effective January 15, 2026. This strategic move comes as Aurora seeks to enhance its growth trajectory in these key markets. Miller’s extensive 35-year background in consumer packaged goods, including notable roles at Reckitt Benckiser and Unilever, positions him as a valuable asset. His experience in leading global initiatives and transformation programs across diverse regions—including Australia, the UK, and several parts of Africa and Asia—aligns seamlessly with Aurora's mission to improve access to medical cannabis.

Miller is expected to leverage his expertise to drive topline growth and expand market share for Aurora in Australia and New Zealand, regions that are increasingly recognizing the therapeutic benefits of cannabis. As the company continues to innovate and diversify its product offerings under established brands like Drift, San Rafael '71, and MedReleaf, Miller's leadership will be critical in navigating the complexities of these markets. His track record of steering teams towards substantial growth will be instrumental in enhancing Aurora's competitive positioning in the medical and wellness cannabis sectors.

The appointment of Miller comes at a crucial time when Aurora is focused on expanding its global footprint and enhancing its product accessibility. The company, known for its commitment to quality and innovation, aims to continue delivering value to patients and stakeholders alike. With a significant investment in Bevo Farms Ltd., a leading supplier of propagated agricultural plants, Aurora demonstrates its dedication to maintaining high standards in cultivation and product development. This strategic expansion under Miller's guidance is expected to bolster Aurora's standing as a pioneer in the cannabis industry.

In addition to its leadership changes, Aurora Cannabis emphasizes its commitment to quality and innovation in the rapidly evolving cannabis landscape. The company's focus on medical, wellness, and recreational cannabis markets showcases its ambition to meet the growing consumer demand and regulatory developments across different regions.

As Aurora prepares for Miller's upcoming leadership, the company remains steadfast in its mission to revolutionize access to medical cannabis while enhancing its market presence globally. For further updates on Aurora's initiatives and product offerings, stakeholders can follow the company on its social media platforms.